[HTML][HTML] Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
JJ Feld, C Kandel, MJ Biondi, RA Kozak… - The Lancet …, 2021 - thelancet.com
Background To date, only monoclonal antibodies have been shown to be effective for
outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate …
outpatients with COVID-19. Interferon lambda-1 is a type III interferon involved in innate …
Predicting antimicrobial resistance in invasive pneumococcal infections
OG Vanderkooi, DE Low, K Green… - Clinical Infectious …, 2005 - academic.oup.com
Background. The prevalence of multiantimicrobial resistance among Streptococcus
pneumoniae continues to increase worldwide. In patients presenting with infection possibly …
pneumoniae continues to increase worldwide. In patients presenting with infection possibly …
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial
Background Despite revised guidelines that no longer exclude people who inject drugs
(PWID) from treatment for hepatitis C virus (HCV) infection, many clinicians are reluctant to …
(PWID) from treatment for hepatitis C virus (HCV) infection, many clinicians are reluctant to …
Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2
We enrolled 91 consecutive inpatients with COVID-19 at 6 hospitals in Toronto, Canada,
and tested 1 nasopharyngeal swab/saliva sample pair from each patient using real-time RT …
and tested 1 nasopharyngeal swab/saliva sample pair from each patient using real-time RT …
The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people
MK Andrew, V Shinde, L Ye, T Hatchette… - The Journal of …, 2017 - academic.oup.com
Background Influenza is an important cause of morbidity and mortality among older adults.
Even so, effectiveness of influenza vaccine for older adults has been reported to be lower …
Even so, effectiveness of influenza vaccine for older adults has been reported to be lower …
[HTML][HTML] Understanding real-world adherence in the directly acting antiviral era: a prospective evaluation of adherence among people with a history of drug use at a …
K Mason, Z Dodd, M Guyton, P Tookey, B Lettner… - International Journal of …, 2017 - Elsevier
Background Direct acting antiviral (DAA) treatments for Hepatitis C (HCV) are now widely
available with sustained virologic response (SVR) rates of> 90%. A major predictor of …
available with sustained virologic response (SVR) rates of> 90%. A major predictor of …
Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs
A Shigayeva, W Rudnick, K Green… - Clinical Infectious …, 2016 - academic.oup.com
Abstract Background. In 2012/2013, a single dose of 13-valent pneumococcal conjugate
vaccine (PCV13) was recommended for immunocompromised adults in the United States …
vaccine (PCV13) was recommended for immunocompromised adults in the United States …
[HTML][HTML] Detection of SARS-CoV-2 from saliva as compared to nasopharyngeal swabs in outpatients
C Kandel, J Zheng, J McCready, MA Serbanescu… - Viruses, 2020 - mdpi.com
Widely available and easily accessible testing for COVID-19 is a cornerstone of pandemic
containment strategies. Nasopharyngeal swabs (NPS) are the currently accepted standard …
containment strategies. Nasopharyngeal swabs (NPS) are the currently accepted standard …
Effectiveness of influenza vaccination on hospitalizations and risk factors for severe outcomes in hospitalized patients with COPD
S Mulpuru, L Li, L Ye, T Hatchette, MK Andrew… - Chest, 2019 - Elsevier
Background The effectiveness of influenza vaccination in reducing influenza-related
hospitalizations among patients with COPD is not well described, and influenza vaccination …
hospitalizations among patients with COPD is not well described, and influenza vaccination …
Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia
B Fischer, J Powis, MF Cruz, K Rudzinski… - European journal of …, 2008 - journals.lww.com
Objective Epidemiological studies present oral crack use as a potential independent risk
factor for hepatitis C virus (HCV) status, yet actual HCV transmission pathways via crack use …
factor for hepatitis C virus (HCV) status, yet actual HCV transmission pathways via crack use …